Share your videos with the world

Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today. Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated. To view the multimedia release go to: https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/

Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers. “The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.” To view the multimedia release go to: https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/

The workbook addresses several concepts and starts with the prevention of relapse. The major part of the workbook is how to develop support systems for maintaining recovery that contribute to successful recovery. The text shows many elements that contribute to addiction. It goes into detail about the genetic aspects of addiction. There is also a segment of how executive functioning of the brain can get impaired with addiction that compromises judgment, impulse control, and the ability to organize. But these impairments can be temporary with practicing having good judgment and impulse control, since new neuropathways can develop with exercising these functions. The stages of recovery and change are reviewed as well as the twelve steps of Alcoholics Anonymous and Narcotics Anonymous. One chapter is dedicated to powerlessness and unmanageability. At the end of each chapter, there are references for the reader to consult that have been used for the content of the workbook chapters. Find out more at https://www.amazon.com/Successful-Recovery-Relapse-Prevention-McCausland-ebook/dp/B079648R6X Non-fiction, self-help